产品标题 |
产品货号 |
产品规格 |
厂家 |
Human ubiquitin-conjugating enzyme E2 variant 1 (UBE2V1), transcript variant 4 from ORIGENE TECHNOLOGIES | TP301824 | 20 ug | ORIGENE TECHNOLOGIES |
Human ubiquitin-conjugating enzyme E2W (putative) (UBE2W), transcript variant 1 from ORIGENE TECHNOLOGIES | TP321130 | 20 ug | ORIGENE TECHNOLOGIES |
Human ubiquitin-conjugating enzyme E2W (putative) (UBE2W), transcript variant 2 from ORIGENE TECHNOLOGIES | TP304985 | 20 ug | ORIGENE TECHNOLOGIES |
Human ubiquitin-conjugating enzyme E2Z (UBE2Z) from ORIGENE TECHNOLOGIES | TP720972 | 50 ug | ORIGENE TECHNOLOGIES |
Even-skipped homeobox 1 (EVX1) from ORIGENE TECHNOLOGIES | LY400729 | 100 ug | ORIGENE TECHNOLOGIES |
Chemokine (C-C motif) ligand 14 (CCL14), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418173 | 100 ug | ORIGENE TECHNOLOGIES |
Chemokine (C-C motif) ligand 14 (CCL14), transcript variant 3 from ORIGENE TECHNOLOGIES | LY409847 | 100 ug | ORIGENE TECHNOLOGIES |
Chemokine (C-C motif) ligand 15 (CCL15), transcript variant 1 from ORIGENE TECHNOLOGIES | LY409848 | 100 ug | ORIGENE TECHNOLOGIES |
Chemokine (C-C motif) ligand 15 (CCL15), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429822 | 100 ug | ORIGENE TECHNOLOGIES |
Chemokine (C-C motif) ligand 15 (CCL15), transcript variant 2 from ORIGENE TECHNOLOGIES | LY418174 | 100 ug | ORIGENE TECHNOLOGIES |
Chemokine (C-C motif) ligand 20 (CCL20), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401468 | 100 ug | ORIGENE TECHNOLOGIES |
Chemokine (C-C motif) ligand 4 (CCL4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401043 | 100 ug | ORIGENE TECHNOLOGIES |
Chemokine (C-C motif) ligand 23 (CCL23), transcript variant CKbeta8 from ORIGENE TECHNOLOGIES | LY407835 | 100 ug | ORIGENE TECHNOLOGIES |
Chemokine (C-C motif) ligand 3-like 1 (CCL3L1) from ORIGENE TECHNOLOGIES | LY412133 | 100 ug | ORIGENE TECHNOLOGIES |
Chemokine (C-C motif) ligand 3-like 3 (CCL3L3) from ORIGENE TECHNOLOGIES | LY424355 | 100 ug | ORIGENE TECHNOLOGIES |
Chemokine (C-C motif) ligand 4-like 1 (CCL4L1) from ORIGENE TECHNOLOGIES | LY424353 | 100 ug | ORIGENE TECHNOLOGIES |
Chemokine (C-C motif) ligand 4-like 2 (CCL4L2) from ORIGENE TECHNOLOGIES | LY404131 | 100 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR561316 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR561331 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR561511 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR561755 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR562085 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR562289 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR562347 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR562441 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR562516 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR562674 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR562707 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR562711 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR562747 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR562765 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR562853 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CR562986 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid, clear cell from ORIGENE TECHNOLOGIES | CR559210 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid, clear cell from ORIGENE TECHNOLOGIES | CR559470 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid, clear cell from ORIGENE TECHNOLOGIES | CR561092 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid, clear cell from ORIGENE TECHNOLOGIES | CR562962 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid, metastatic from ORIGENE TECHNOLOGIES | CR560241 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid, metastatic from ORIGENE TECHNOLOGIES | CR560639 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid, metastatic from ORIGENE TECHNOLOGIES | CR560754 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid, metastatic from ORIGENE TECHNOLOGIES | CR561447 | 5 ug | ORIGENE TECHNOLOGIES |
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid, metastatic from ORIGENE TECHNOLOGIES | CR561527 | 5 ug | ORIGENE TECHNOLOGIES |
Human vitamin K epoxide reductase complex, subunit 1 (VKORC1), transcript variant 2 from ORIGENE TECHNOLOGIES | TP314831 | 20 ug | ORIGENE TECHNOLOGIES |
Human vitelline membrane outer layer 1 homolog (chicken) (VMO1), transcript variant 3 from ORIGENE TECHNOLOGIES | TP720495 | 10 ug | ORIGENE TECHNOLOGIES |
Human vitelline membrane outer layer 1 homolog (chicken) (VMO1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP321753 | 20 ug | ORIGENE TECHNOLOGIES |
Glycine cleavage system protein H (aminomethyl carrier) (GCSH), nuclear gene encoding mitochondrial protein, transcript variant 1 from ORIGENE TECHNOLOGIES | LY417961 | 100 ug | ORIGENE TECHNOLOGIES |
Glycine dehydrogenase (decarboxylating) (GLDC), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIES | LY424873 | 100 ug | ORIGENE TECHNOLOGIES |
KCTD4 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305394 | 10 ug | ORIGENE TECHNOLOGIES |
KCTD5 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH300180 | 10 ug | ORIGENE TECHNOLOGIES |
KCTD6 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH325297 | 10 ug | ORIGENE TECHNOLOGIES |